Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
Monica O'Connor and at least two other people were killed in the incident, and a British man remains missing.
Lively downpours across the south, Wales and Northern Ireland today - slow moving and intense with hail and thunder.
"The council's inspector judged there was an imminent health risk and an immediate voluntary closure of the takeaway was agreed."